[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.232.62.209. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
November 11, 1939

Sulphonamide Treatment of Experimental Tuberculosis in Guinea Pigs

JAMA. 1939;113(20):1835. doi:10.1001/jama.1939.02800450057032

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

No medical institute worthy of the name exists which has not been intrigued by the possibilities of research with the drug sulfanilamide or its derivatives. In fact, not since the epoch-making discovery of Ehrlich has a new chemotherapeutic agent received such universal scientific recognition as sulfanilamide. Dr. Konrad Birkhaug in his lecture delivered at the annual meeting of the Christian Michelsen Institute, Bergen (March 14, 1939), reviews much of the work which has already been covered in the enormous medical archives of the past three years. In his lecture he reviews the chemistry of the various compounds. He states: "Happily, this cumbersome chemical name has been abbreviated by the Council on Pharmacy and Chemistry of the American Medical Association to sulfanilamide." In his lecture he pays particular attention to the work on sulfanilamide as outlined by Marshall, Emerson and Cutting and discusses thoroughly the dosage and chemotherapeutic range of the

First Page Preview View Large
First page PDF preview
First page PDF preview
×